Blastomycosis is a fungal infection caused by inhaling spores of Blastomyces, a soil-dwelling organism found mainly in parts of North America and Africa. It typically starts in the lungs and can spread to the skin, bones, and other organs if the immune system fails to contain it. What makes blastomycosis particularly troublesome is how easily it masquerades as something else: roughly two in five patients experience at least one missed diagnostic opportunity before a correct diagnosis is made, and the average delay runs close to three weeks. Understanding where this fungus lives, how it causes disease, and why it slips past clinicians so often matters for anyone living in or visiting endemic regions.
Where Blastomyces Lives
The fungus thrives in moist, organic-rich soil, particularly along riverbanks, in wooded areas, and near decaying vegetation.1PubMed Central. Assessment of environmental risk factors for blastomycosis during a large outbreak at a Michigan paper mill Its traditional endemic zone in North America centers on the Ohio and Mississippi River Valleys and the Great Lakes region.2Emerging Infectious Diseases. Emerging Endemic Area for Blastomycosis, New York, USA, 2000–2024 In Canada, northwestern Ontario is a major hotspot, with localized areas reporting about 11 cases per 100,000 people, more than twelve times higher than elsewhere in the province.3PubMed Central. Epidemiology and Geographic Distribution of Blastomycosis, Histoplasmosis, and Coccidioidomycosis, Ontario, Canada, 1990-2015 Beyond North America, the Blastomyces dermatitidis species complex is also endemic in central, eastern, and southern Africa and in India.4PubMed Central. Re-drawing the Maps for Endemic Mycoses
Pinpointing exactly where Blastomyces hides in the soil has proven difficult. The fungus seems to concentrate in tiny pockets, or “microfoci,” rather than carpeting wide stretches of ground. Environmental modeling in Minnesota identified latitude, longitude, elevation, and site type as factors predicting the fungus’s presence, and a predictive model achieved about 75 percent accuracy at identifying contaminated soil samples.5PubMed Central. Analysis and modeling of Blastomyces dermatitidis environmental prevalence in Minnesota using soil collected to compare basal and outbreak levels That sounds decent on paper, but it also means one in four predictions was wrong, reflecting how patchy the fungus’s distribution really is.
How You Get Infected
Infection begins when contaminated soil is disturbed and tiny fungal spores, called conidia, become airborne. You breathe them in, and they land in the lungs.6PubMed Central. Clinical and laboratory update on blastomycosis Activities that churn up dirt are the common thread. In a Wisconsin study spanning decades, about 69 percent of blastomycosis patients recalled some soil-disturbing activity before getting sick. Excavation, gardening, and simply living near wooded or waterfront areas were the most frequent exposures.7Journal of Patient-Centered Research and Reviews. Pulmonary Blastomycosis in Vilas County, Wisconsin: Weather, Exposures and Symptoms Humidity and rainfall encourage spore release, but the relationship with weather is not straightforward. One rural cluster was linked not to heavy rain but to a sustained five-year stretch of low precipitation, which may have exposed normally wet soil.8PubMed. Cluster of pulmonary blastomycosis in a rural community: evidence for multiple high-risk environmental foci following a sustained period of diminished precipitation Person-to-person transmission essentially does not happen. You catch it from the environment, not from another person.
The Shape-Shifting Trick That Makes It Dangerous
Blastomyces belongs to a group called thermally dimorphic fungi, meaning it takes on two different forms depending on temperature. In cool soil, it grows as thread-like filaments (hyphae) that produce the infectious spores. Once those spores reach the warm environment of human lungs, they transform into large, thick-walled yeast cells.9PubMed Central. Clinical Manifestations and Treatment of Blastomycosis This switch is not just cosmetic. The yeast form activates a key virulence factor called BAD1, a surface protein that helps the fungus stick to host cells, suppress immune-cell activation, and dampen the release of signaling molecules the body uses to coordinate its defenses.10PubMed Central. Turning on virulence: Mechanisms that underpin the morphologic transition and pathogenicity of Blastomyces BAD1 production is switched on only in the yeast phase, meaning the filamentous form in the soil is essentially non-virulent.11PubMed Central. Sequence elements necessary for transcriptional activation of BAD1 in the yeast phase of Blastomyces dermatitidis
The immune system’s best bet at clearing the yeast relies heavily on a type of white blood cell response driven by a signaling molecule called IL-17A. Vaccine research in animal models has shown that protective immunity against Blastomyces depends on strong IL-17A signaling and robust activity from neutrophils and other immune cells in the lungs. When either component is missing, vaccinated animals lose much of their ability to fight off the infection.12PubMed Central. Helper T‐cell responses and pulmonary fungal infections No human vaccine exists yet, but this work is shaping what a future one might look like.
What Blastomycosis Looks Like
The lungs are almost always the starting point. Symptoms range from none at all to a full-blown pneumonia with cough, fever, chest pain, and shortness of breath. The trouble is that these symptoms overlap completely with ordinary bacterial pneumonia, so clinicians often reach for antibiotics first. In one case series, 93 percent of patients received antibacterial treatment before anyone considered a fungal cause.13PubMed Central. Diagnostic Delay in Pulmonary Blastomycosis: A Case Series Reflecting a Referral Center Experience
If the lungs cannot contain the infection, the fungus spreads through the bloodstream to other organs. Up to two-thirds of patients develop disease outside the lungs, most often affecting the skin, bones, and genitourinary system.14JAAD Case Reports. Three cases of cutaneous blastomycosis in immunocompetent patients Skin involvement often shows up as raised, warty or ulcerated lesions, sometimes mistaken for skin cancer. Bone involvement can mimic osteomyelitis or metastatic cancer. This chameleon quality is one of blastomycosis’s defining features.
At the severe end of the spectrum, blastomycosis can trigger acute respiratory distress syndrome (ARDS), which is rare but carries a high fatality rate. Delayed diagnosis in these cases is frequently a contributing factor.15PubMed Central. Fatal Pulmonary Failure-A Rare Case of Blastomycosis Induced Acute Respiratory Distress Syndrome: A Case Report and Literature Review
Why It Gets Misdiagnosed So Often
Blastomycosis has a serious recognition problem. In a study of nearly 3,800 patients, 41 percent had at least one missed diagnostic opportunity, averaging about 3.2 healthcare visits before someone ordered the right test. The average diagnostic delay was roughly 27 days, and 17 percent waited over a month. Most of these missed opportunities happened in outpatient settings, where a patient with cough and fever gets treated as a routine pneumonia case and sent home.16Medical Mycology. The incidence, duration, and risk factors for diagnostic delays associated with blastomycosis A separate referral-center study found a median delay of 20 days, with the biggest gap occurring between the first clinical encounter and the first order for a fungal test, a median of 15 days of simply not thinking to look.17PubMed Central. Diagnostic Delay in Pulmonary Blastomycosis: A Case Series Reflecting a Referral Center Experience
The mimicry goes beyond bacterial pneumonia. Chronic pulmonary blastomycosis is frequently misdiagnosed as tuberculosis, particularly in regions where TB is common.18PubMed Central. Blastomycosis Misdiagnosed as Tuberculosis, India It can also present with imaging features indistinguishable from lung cancer, including mass-like lesions and lymph node enlargement, sometimes leading to unnecessary biopsies or even surgery before the true cause is found.19PubMed Central. Pulmonary blastomycosis presenting as primary lung cancer During the early COVID-19 pandemic, diagnostic delays for blastomycosis may have worsened, as respiratory symptoms were funneled toward a COVID-first evaluation pathway.20CMI Communications. Histoplasmosis and blastomycosis: Progress and possibilities
How It Is Diagnosed
The gold standard remains growing the fungus from a clinical sample, such as sputum or tissue, and visually identifying the characteristic large, round yeast cells with broad-based budding under a microscope.21PubMed Central. Clinical and laboratory update on blastomycosis That broad-based bud is the organism’s visual fingerprint, distinguishing it from other fungi. The downside is that cultures can take weeks to grow.
Urine antigen testing offers a faster alternative. One evaluation found the Blastomyces urine antigen test had about 88 percent sensitivity and 98 percent specificity when compared against culture-confirmed cases. By contrast, older antibody-based blood tests performed poorly: only 2 out of 20 culture-positive patients tested positive by antibody methods.22PubMed Central. Use of Urine Antigen Testing for Blastomyces in an Integrated Health System That said, antigen testing is not as reliable as its best numbers suggest. A ten-year evaluation in an endemic area found that antigen testing was less sensitive than earlier reports implied, though serial urine testing proved useful for tracking whether treatment was working.23PubMed Central. Blastomyces Antigen Detection for Diagnosis and Management of Blastomycosis Cross-reactivity with related fungi like Histoplasma is another known limitation. In practice, most clinicians use a combination of culture, microscopy, and antigen testing rather than relying on any single method.
Who Faces Higher Risk
An important and sometimes surprising feature of blastomycosis is that it regularly infects healthy people. You do not need a weakened immune system to develop serious disease. Many patients in outbreak investigations have no underlying conditions at all. That said, people who are immunocompromised do worse. A study comparing outcomes found that immunosuppressed patients had higher rates of severe infection, respiratory failure, and death than those with intact immunity. Solid organ transplant recipients were hit hardest, with an 18-fold higher annual incidence of blastomycosis compared with the general population and substantially higher mortality.24PubMed Central. Clinical Manifestations and Outcomes in Immunocompetent and Immunocompromised Patients With Blastomycosis
Interestingly, the rate of disseminated disease (spread beyond the lungs) was similar across both immunocompetent and immunocompromised groups.25Clinical Infectious Diseases. Clinical Manifestations and Outcomes in Immunocompetent and Immunocompromised Patients With Blastomycosis This reinforces the point that dissemination is not strictly a marker of immune weakness. Anyone with blastomycosis can develop skin or bone involvement regardless of their baseline health.
Treatment
The backbone of blastomycosis treatment is an antifungal drug called itraconazole. For mild to moderate disease, current guidelines recommend oral itraconazole for six to twelve months. For moderate-to-severe or life-threatening cases, treatment typically begins with a course of intravenous amphotericin B for one to two weeks to get the infection under control, then transitions to oral itraconazole for the remainder of the treatment period.26Clinical Infectious Diseases. Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America
One practical wrinkle with itraconazole is that blood levels of the drug vary widely from person to person. Monitoring those levels matters because too little drug means the infection may not clear, and too much can cause side effects. Research supports a combined target level of itraconazole and its active breakdown product of over 1.0 micrograms per milliliter for effective treatment.27PubMed. Does metabolite matter? Defining target itraconazole and hydroxy-itraconazole serum concentrations for blastomycosis Most patients can be treated entirely as outpatients if the disease is caught while still mild. The months-long treatment course, however, demands patience and follow-up. Stopping too early is a common cause of relapse.
Blastomycosis in Dogs
Dogs get blastomycosis at a much higher rate than humans do, and they serve as an early warning signal. Because dogs sniff the ground and dig in soil, they encounter the fungus more readily. A diagnosis of blastomycosis in a dog tells public health officials that the fungus is active in a particular area. Dogs are considered sentinels for human exposure, though direct transmission from a dog to a person does not normally occur. Rare cases have been reported only through bite-wound inoculation, not through casual contact.28ScienceDirect. Greene’s Infectious Diseases of the Dog and Cat A case-control study looking for a statistical link between canine and human blastomycosis in the same households did not find a significant association, meaning a sick dog in your home does not make you more likely to get sick yourself (though it does suggest you share an environment where the fungus lives).29PubMed Central. Risk factors for acquisition of endemic blastomycosis
Treating dogs follows a similar approach to treating humans: itraconazole is the standard drug. Veterinary research, however, has shown that most dogs need repeated dosage adjustments to keep blood levels in the target range. In one study, about two-thirds of dogs required at least one adjustment even during the maintenance phase of treatment, suggesting that periodic drug-level monitoring should continue throughout the entire course rather than stopping once a good level is first achieved.30PubMed Central. Therapeutic drug monitoring of itraconazole in treatment of blastomycosis in dogs
Surveillance Gaps
One of the less obvious problems with blastomycosis is that we do not have a good handle on how common it actually is. Only five U.S. states require that cases be reported to the health department: Arkansas, Louisiana, Michigan, Minnesota, and Wisconsin.31Emerging Infectious Diseases. Emerging Endemic Area for Blastomycosis, New York, USA, 2000–2024 In every other state, cases can occur without anyone tallying them. That means the geographic boundaries of the endemic zone are probably broader than the maps suggest. New York, for example, has begun identifying locally acquired cases in areas not previously considered endemic. Without mandatory reporting, outbreaks in new areas can simmer for years before anyone notices a pattern.
The situation is even murkier outside North America. African cases are likely underreported because the diagnostic tools are less available, and the chronic lung symptoms are frequently attributed to tuberculosis instead.32PubMed Central. Blastomycosis Misdiagnosed as Tuberculosis, India India has documented cases as well, yet the true burden there remains almost completely unknown.
Two Species, Not One
For most of its medical history, blastomycosis was attributed to a single species, Blastomyces dermatitidis. Genetic analysis revealed a cryptic second species, now called Blastomyces gilchristii, hiding within what had been treated as one organism.33PLOS ONE. Phylogenetic Analysis Reveals a Cryptic Species Blastomyces gilchristii, sp. nov. within the Human Pathogenic Fungus Blastomyces dermatitidis The two species diverged an estimated 1.9 million years ago and show distinct geographic clustering tied to freshwater drainage basins across North America.34PLOS ONE. Phylogeographic Analysis of Blastomyces dermatitidis and Blastomyces gilchristii Reveals an Association with North American Freshwater Drainage Basins
The genomes of the two species look fairly similar in terms of the proteins they encode, but they differ markedly in size. B. gilchristii genomes run about 73 to 75 megabases, roughly 8 megabases larger than B. dermatitidis. Most of that extra DNA comes from an accumulation of mobile genetic elements called retrotransposons rather than from extra functional genes.35PubMed Central. Comparative genome analysis and the genome-shaping role of long terminal repeat retrotransposons in the evolutionary divergence of fungal pathogens Blastomyces dermatitidis and Blastomyces gilchristii From a patient’s perspective, this split has not yet changed treatment. Both species cause the same clinical disease and respond to the same antifungal drugs. But the distinction could eventually matter for epidemiology, vaccine development, or understanding why some regions see more severe outbreaks than others. A third species, Blastomyces helicus, has also been identified and tends to cause disease in different geographic pockets, adding another layer to what was once thought to be a straightforward single-pathogen story.
Weather, Climate, and Outbreak Patterns
The relationship between weather and blastomycosis outbreaks is real but not simple. Precipitation patterns appear to matter, though the timing is indirect. The Wisconsin data showed that total precipitation from about a year earlier explained roughly a fifth of the seasonal variation in case counts.36Journal of Patient-Centered Research and Reviews. Pulmonary Blastomycosis in Vilas County, Wisconsin: Weather, Exposures and Symptoms Wet conditions may encourage fungal growth in soil, but there is a lag before spores are produced and then disturbed into the air. Conversely, as noted in the rural cluster study, prolonged drought can also set the stage for outbreaks by dropping water levels and exposing riverbanks and lakeshores rich in organic material that the fungus colonizes.37PubMed. Cluster of pulmonary blastomycosis in a rural community: evidence for multiple high-risk environmental foci following a sustained period of diminished precipitation Both too much rain and too little, in different ways, can promote conditions the fungus exploits. Climate change is likely reshaping the endemic zone, but the patchiness of surveillance data makes it hard to say exactly how fast or in which direction.